SCHEMBL286

SCHEMBL286

C=CCC(C(=O)OCC)C(=O)c1ccc(C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 4/20 0.51
SLC6A2 P23975 3/20 0.51
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 5/20 0.42
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 2/20 0.39
GSK3B P49841 1/20 0.39
SLC6A4 P31645 2/20 0.38
DHODH Q02127 1/20 0.37
PKM P14618 2/20 0.37
HTT P42858 2/20 0.37
ATM Q13315 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HPGD P15428 2/20 0.37
NLRP1 Q9C000 1/20 0.37
NTSR1 P30989 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10533897 0.94 SLC6A3 (0.47) SLC6A3SLC6A2KMT2AMEN1L3MBTL1
SCHEMBL9647321 0.88 MEN1 (0.49) KMT2AMEN1MAPK1ALDH1A1LMNA
SCHEMBL596 0.86 KMT2A (0.47) SLC6A3SLC6A2KMT2AMEN1ALDH1A1
SCHEMBL28234879 0.81 SLC6A2 (0.54) SLC6A3SLC6A2KMT2AMEN1MAPK1
SCHEMBL11097089 0.79 KMT2A (0.47) KMT2AMEN1L3MBTL1MAPK1ALDH1A1
SCHEMBL793641 0.78 ALDH1A1 (0.40) KMT2AMEN1L3MBTL1MAPK1ALDH1A1
SCHEMBL10533900 0.78 L3MBTL1 (0.36) SLC6A3SLC6A2KMT2AMEN1L3MBTL1
SCHEMBL9647401 0.77 TDP1 (0.45) SLC6A3SLC6A2KMT2AMEN1L3MBTL1
SCHEMBL9650914 0.76 KMT2A (0.46) KMT2AMEN1L3MBTL1MAPK1ALDH1A1
SCHEMBL1825614 0.76 LMNA (0.43) KMT2AMEN1L3MBTL1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733366-B1 Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics DU PONT (US) 1998-04-01 EP disclosed
EP-0324377-B1 Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids DU PONT (US) 1997-04-16 EP disclosed
EP-0733366-A2 Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-09-25 EP disclosed
EP-0253310-B1 Angiotensin II receptor blocking imidazoles DU PONT (US) 1994-10-26 EP disclosed
US-5155118-A Administering angiotensin inhibitor E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-10-13 US disclosed
US-5153197-A Treatment of hypertension with angiotensin II blocking imidazoles E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-10-06 US disclosed
US-5138069-A Treating hypertension and congestive heart failure E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-08-11 US disclosed
US-5128355-A Hypotensive E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-07-07 US disclosed
EP-0324377-A2 Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-07-19 EP disclosed
WO-1989006233-A1 ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLES AND COMBINATIONS THEREOF WITH DIURETICS AND NSAIDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-07-13 WO disclosed
EP-0253310-A2 Angiotensin II receptor blocking imidazoles E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-01-20 EP disclosed